Abstract
Background
Febrile infection-related epilepsy syndrome (FIRES) is a rare and catastrophic clinical
syndrome occurring in previously healthy patients. Aetiology is still unknown and
outcome usually poor. We describe a case of myoclonic prolonged super refractory status
epilepticus (P-SRSE) in FIRES in a patient admitted to the paediatric intensive care
unit of Padova, Italy.
Case report
A previously healthy 14-year-old girl with onset of myoclonic status epilepticus after
a mild febrile illness was admitted to our hospital with a diagnosis of FIRES. Extensive
diagnostic work-up was inconclusive. Status epilepticus and electroclinical seizures
recurred every time weaning from anaesthetic agents was attempted. Eventually, a vagal
nerve stimulator (VNS) was implanted and cannabidiol (CBD) administered, 43 days and
70 days after P-SRSE onset, respectively. Two days after CBD introduction, status
epilepticus weaned and the girl rapidly regained complete consciousness showing a
brilliant and unexpected recovery. At last follow-up, 12 months later, she is 8-months
seizure free on multiple antiseizure medications, has only mild neuropsychological
impairment with no neurological and intellective deficit.
Conclusions
To our knowledge, this represents a unique case with an extremely favourable evolution
with a possible effect of the association of VNS and CBD to traditional antiseizure
medications.
Keywords
Abbreviations:
CBD (cannabidiol), FIRES (febrile infection-related epilepsy syndrome), KD (ketogenic diet), NORSE (new-onset refractory status epilepticus), RSE (refractory status epilepticus), VNS (vagal nerve stimulation)To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Brain and DevelopmentAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- International League Against Epilepsy classification and definition of epilepsy syndromes with onset in childhood: Position paper by the ILAE Task Force on Nosology and Definitions.Epilepsia. 2022; 63: 1398-11342
- Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions.Epilepsia. 2018; 59: 739-744
- New-onset refractory status epilepticus and febrile infection-related epilepsy syndrome.Dev Med Child Neurol. 2020; 62: 897-905
- Claustrum damage and refractory status epilepticus following febrile illness.Neurology. 2015; 85: 1224-1232
- Early ictal and interictal patterns in FIRES: The sparks before the blaze.Epilepsia. 2017; 58: 1340-1348
- Proposal to optimize evaluation and treatment of Febrile infection-related epilepsy syndrome (FIRES): A Report from FIRES workshop.Epilepsia Open. 2021; 6: 62-72
- International consensus recommendations for management of New Onset Refractory Status Epilepticus (NORSE) incl. Febrile Infection-Related Epilepsy Syndrome (FIRES): Statements and Supporting Evidence.Epilepsia. 2022; 63: 2840-2864
- Vagus Nerve Stimulation (VNS) in Super Refractory New Onset Refractory Status Epilepticus (NORSE).Case Rep Neurol Med. 2019; 2019: 7852017
- Vagus nerve stimulation in refractory and super-refractory status epilepticus - A systematic review.Brain Stimul. 2019; 12: 1101-1110
- The Cannabinoids International Experts Panel; Collaborators. Epilepsy and cannabidiol: a guide to treatment.Epileptic Disord. 2020; 22: 1-14
- High dose cannabidiol (CBD) in the treatment of new-onset refractory status epilepticus (NORSE).Seizure. 2022; 94: 126-128
- Cannabidiol in Dravet Syndrome Study Group. Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome.N Engl J Med. 2017; 376: 2011-2020
- Cannabidiol as a Potential Treatment for Febrile Infection-Related Epilepsy Syndrome (FIRES) in the Acute and Chronic Phases.J Child Neurol. 2017; 32: 35-40
- Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders.Epilepsia. 2014; 55: 791-802
Article info
Publication history
Published online: January 30, 2023
Accepted:
January 16,
2023
Received in revised form:
January 11,
2023
Received:
September 18,
2022
Identification
Copyright
© 2023 Published by Elsevier B.V. on behalf of The Japanese Society of Child Neurology. All rights reserved.